PETDX
San Diego, United States · $72.0M raised
- Headquarters
- San Diego, California
- Business Model
- B2B
- Total Funding
- $72.0M
- Last Round
- $62.0M Series BDec 2021
- Rounds
- 2
About
PetDx is a San Diego-based molecular diagnostics company using liquid biopsy genomics to detect and monitor cancer in pets.
Summary
PETDX is a Biotech company based in San Diego, United States. It has raised $72.0M in total across 2 rounds, most recently a $62.0M Series B round in Dec 2021. Investors include Friedman Bioventure.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...